StockComparison Logo
vs

ECL vs VRNA

Comparison between Ecolab Inc (ECL, Company) and Verona Pharma Plc (VRNA, Company).

ECL is from the Basic Materials sector, while VRNA is from the Healthcare sector.

5-Year PerformanceVRNA has outperformed ECL, delivering a return of +77.1% compared to +6.0%

ECL vs VRNA - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
ECL
$78B
VRNA
$78B
Max Drawdown
Winner
ECL
44.27%
VRNA
89.71%
Sharpe Ratio
ECL
-0.08
Winner
VRNA
2.69
5Y Beta
ECL
0.55
VRNA
N/A
Industry
ECL
Specialty Chemicals
VRNA
Biotechnology
P/E Ratio
ECL
37.07
Winner
VRNA
-852.67
Forward P/E
ECL
35.09
VRNA
N/A
PEG Ratio
ECL
2.93
VRNA
N/A
Dividend Yield
ECL
0.99%
VRNA
N/A
5Y Dividends CAGR
ECL
12.81%
VRNA
N/A
5Y EPS CAGR
ECL
15.19%
VRNA
N/A
Debt to Equity
Winner
ECL
12.59%
VRNA
87.12%
Free Cash Flow Yield
Winner
ECL
2.40%
VRNA
-0.09%
P/S Ratio
Winner
ECL
4.60
VRNA
350.73
P/B Ratio
Winner
ECL
7.93
VRNA
279.39

ECL vs VRNA - Historical Returns

Returns include dividend reinvestment.

1M
Winner
ECL
+6.60%
VRNA
+0.57%
3M
ECL
+12.87%
Winner
VRNA
+17.23%
6M
ECL
-6.91%
Winner
VRNA
+96.89%
1Y
ECL
+0.56%
Winner
VRNA
+233.57%
5Y(CAGR)
ECL
+6.03%
Winner
VRNA
+77.09%
10Y(CAGR)
ECL
+9.89%
Winner
VRNA
+27.76%
Max(CAGR)
ECL
+12.31%
Winner
VRNA
+27.76%

ECL vs VRNA - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearECLVRNA
2026+7.80%N/A
2025+14.86%+121.80%
2024+19.38%+146.89%
2023+36.39%-18.79%
2022-35.81%+275.43%
2021+10.43%-5.35%
2020+14.84%+23.35%
2019+34.50%-40.41%
2018+10.82%-21.80%
2017+14.99%-12.07%
2016+5.49%N/A
2015+10.96%N/A
2014+1.78%N/A
2013+41.80%N/A
2012+25.51%N/A
2011+16.03%N/A
2010+12.94%N/A
2009+26.29%N/A
2008-30.26%N/A
2007+16.30%N/A
2006+27.89%N/A
2005+5.97%N/A
2004+31.30%N/A
2003+10.63%N/A
2002+24.85%N/A
2001-3.99%N/A
2000+16.11%N/A
1999+14.60%N/A

ECL vs VRNA Drawdown Comparison

The maximum drawdown for ECL was -43.71%, occurring on Nov 3, 2022. Recovery took 560 trading sessions.

The maximum drawdown for VRNA was -89.71%, occurring on Mar 18, 2020. Recovery took 1189 trading sessions.

The current ECL drawdown is -8.18%.

RankECLVRNA
#1-43.71%
Dec 29, 2021 - Mar 22, 2024
-89.71%
Apr 4, 2018 - Dec 21, 2022
#2-41.95%
Dec 24, 2007 - Sep 20, 2010
-56.07%
Dec 30, 2022 - Aug 13, 2024
#3-40.29%
Feb 19, 2020 - May 28, 2020
-36.28%
Sep 11, 2017 - Mar 15, 2018
#4-30.47%
Jan 10, 2000 - May 11, 2000
-29.89%
May 23, 2017 - Sep 7, 2017
#5-30.00%
Dec 28, 2000 - Feb 15, 2002
-22.59%
Feb 28, 2025 - Apr 29, 2025
#6-22.73%
May 31, 2002 - Aug 8, 2002
-13.51%
Apr 29, 2025 - May 20, 2025
#7-21.55%
Jul 1, 2011 - Nov 30, 2011
-12.37%
Nov 11, 2024 - Nov 27, 2024
#8-20.09%
Feb 27, 2026 - May 19, 2026
-10.66%
Jun 24, 2025 - Jul 9, 2025
#9-19.85%
Jun 8, 2020 - May 4, 2021
-10.54%
Mar 26, 2018 - Apr 4, 2018
#10-17.73%
Oct 16, 2015 - Jun 8, 2016
-8.78%
Jan 7, 2025 - Jan 15, 2025
#11-16.18%
Aug 19, 2002 - Oct 28, 2002
-8.36%
Sep 16, 2024 - Oct 3, 2024
#12-16.16%
Mar 3, 2025 - Jun 10, 2025
-8.20%
Feb 21, 2025 - Feb 28, 2025
#13-16.14%
May 12, 2000 - Nov 21, 2000
-7.93%
Mar 20, 2018 - Mar 26, 2018
#14-15.94%
Sep 19, 2014 - Jun 18, 2015
-7.47%
Dec 27, 2022 - Dec 29, 2022
#15-13.81%
Nov 30, 2018 - Feb 11, 2019
-7.07%
Aug 21, 2024 - Sep 10, 2024

Correlation

Correlation between ECL and VRNA is 0.61 which considered as a moderate positive correlation - the stocks show some tendency to move together.

0.61
-101

Select Stocks to Compare